Literature DB >> 19710137

Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.

Jianhong Hu1, Eugene Liu, Rolf Renne.   

Abstract

Kaposi's sarcoma-associated herpesvirus (also named human herpesvirus 8) is a gamma-herpesvirus that undergoes both lytic and latent infection. During latent infection, two viral elements are required: latency-associated nuclear antigen (LANA), which functions as an origin binding protein, and the latent origin, which resides within the terminal repeats (TRs) of the viral genome. Previously, we identified two cis-elements within the TRs which are required for latent DNA replication: two LANA binding sites (LBS1 and LBS2 [LBS1/2]) and a GC-rich replication element (RE) upstream of LBS1/2. To further characterize the RE, we constructed a 71-bp minimal replicon (MR) and performed a detailed mutational analysis. Our data indicate that the first 8 nucleotides within the RE are critical for replication. Moreover, both the position and the distance between the RE and LBS1/2 can affect origin replication activity, suggesting that the RE may function as a loading pad for cellular proteins involved in replication. Using biotinylated DNA fragments of wild-type or mutant MRs as probes, we identified 30 proteins that preferentially bind to the origin. Among these proteins, structure-specific recognition protein 1 (SSRP1), a subunit of the FACT complex, and telomeric repeat binding factor 2 (TRF2) formed complexes with LANA at the MR region. Furthermore, the small interfering RNA-based knockdown of SSRP1, but not the dominant-negative-based knockdown of TRF2, significantly decreased the efficiency of LANA-dependent DNA replication. These results indicate that SSRP1 is a novel cellular protein involved in LANA-dependent DNA replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710137      PMCID: PMC2772803          DOI: 10.1128/JVI.00907-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres.

Authors:  X D Zhu; B Küster; M Mann; J H Petrini; T de Lange
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

2.  Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.

Authors:  G M Platt; G R Simpson; S Mittnacht; T F Schulz
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  The minimal replicator of Epstein-Barr virus oriP.

Authors:  J L Yates; S M Camiolo; J M Bashaw
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.

Authors:  T Piolot; M Tramier; M Coppey; J C Nicolas; V Marechal
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Interaction of human Ku70 with TRF2.

Authors:  K Song; D Jung; Y Jung; S G Lee; I Lee
Journal:  FEBS Lett       Date:  2000-09-08       Impact factor: 4.124

6.  Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.

Authors:  A Schepers; M Ritzi; K Bousset; E Kremmer; J L Yates; J Harwood; J F Diffley; W Hammerschmidt
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

7.  Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells.

Authors:  A Krithivas; D B Young; G Liao; D Greene; S D Hayward
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells.

Authors:  S A Radkov; P Kellam; C Boshoff
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

9.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity.

Authors:  Chunghun Lim; Hekwang Sohn; Yousang Gwack; Joonho Choe
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

10.  Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.

Authors:  Subhash C Verma; Tathagata Choudhuri; Rajeev Kaul; Erle S Robertson
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more
  19 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.

Authors:  Franceline Juillard; Erika De León Vázquez; Min Tan; Shijun Li; Kenneth M Kaye
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 5.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.

Authors:  Magdalena Weidner-Glunde; Giuseppe Mariggiò; Thomas F Schulz
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.

Authors:  Crystal Woodard; Gangling Liao; C Rory Goodwin; Jianfei Hu; Zhi Xie; Thaila F Dos Reis; Rob Newman; Heesool Rho; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

7.  The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.

Authors:  Shijun Li; Min Tan; Franceline Juillard; Rajesh Ponnusamy; Bruno Correia; J Pedro Simas; Maria A Carrondo; Colin E McVey; Kenneth M Kaye
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

8.  A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.

Authors:  Erika De León Vázquez; Franceline Juillard; Bernard Rosner; Kenneth M Kaye
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

9.  The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence.

Authors:  Erika De León Vázquez; Kenneth M Kaye
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 10.  Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas.

Authors:  Sangmin Kang; Jinjong Myoung
Journal:  J Microbiol       Date:  2017-04-29       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.